Redwire Space
completed on-orbit operations for a cancer therapeutic and other pharmaceutical investigations launched to the International Space Station, and operates a commercial mission program advancing in-space pharmaceutical development.
- Country
- United States
- Ticker
- RDW
Commercial
Coverage
| CN | EU | US | |
|---|---|---|---|
| cross-sector-intersections | ✓ | ✓ | ✓ |
| upstream-bioreactors | ✓ | ✓ | ✓ |
Regulatorsfdafaa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| In-space organ bioprinting | cross-sector-intersections | High | → |
| Space bioeconomy | upstream-bioreactors | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.